Please login to the form below

PrEP

This page shows the latest PrEP news and features for those working in and with pharma, biotech and healthcare.

GSK’s ViiV submits application for cabotegravir to EMA for HIV-1 prevention

The studies demonstrated that cabotegravir long-acting for PrEP was superior to daily oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), with clinical trial participants experiencing a 69% lower rate of HIV ... Cabotegravir long-acting for PrEP

Latest news

Merck to initiate phase 3 HIV-1 clinical programme with a lower dose of islatravir

Participants in the ongoing phase 3 PrEP once-monthly oral studies will continue to be monitored, the company stated.
GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention

Though oral PrEP treatment options are available in many countries, their impact has been limited in some populations as a result of challenges with adherence and stigma. ... The announcement follows the first regulatory approval of cabotegravir LA for
MHRA grants approval for AstraZeneca’s Evusheld in the UK

It is the first antibody combination for pre-exposure prophylaxis (PrEP) against COVID-19 to be licensed in the UK.
EMA launches rolling review of J&J’s COVID-19 vaccine

J&J is also in talks with other global health regulatory authorities as it preps regulatory review processes for the COVID-19 vaccine to be used during the pandemic response period.
UK could approve Pfizer’s COVID-19 vaccine this week

The report, which cited government sources, said that British medicines regulators were launching a formal review of the vaccine and added that the NHS has been told to prep itself to

More from news
Approximately 3 fully matching, plus 42 partially matching documents found.

Latest Intelligence

The need for automation in healthcare

After this, from transferring samples into an automatable format through 3D printing hardware, to extraction of RNA from the samples and plate prep for the thermocycling PCR analysis, every subsequent stage
Redefining communications excellence

In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A survey run in 2014 and 2015 found two-thirds of primary care physicians had never discussed Truvada for PrEP with their patients.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

World AIDS Day 2018: Fighting the stigma surrounding HIV

14. Both pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) drugs may prevent infection developing. ... PrEP (pre-exposure prophylaxis). Available at: . Accessed November 2018. NHS. Can post-exposure prophylaxis (PEP) stop me getting HIV?
Research Partnership

Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

The Creative Engagement Group

We create experiences that inspire lasting change. Exceptional experiences that engage people, change mindsets and behaviour, enrich cultures, increase skills...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password:

Please login to the form below

PrEP

Subscribe to our email news alerts

Quick links